Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.
Open Access
- 1 December 1985
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 69 (12) , 909-910
- https://doi.org/10.1136/bjo.69.12.909
Abstract
The interaction between bromocriptine and metoclopramide on intraocular pressure (IOP), pupil diameter, and other parameters were studied in healthy volunteers. Pupil diameter was not affected by both treatments and only bromocriptine lowered IOP. Prior treatment with metoclopramide blocked the IOP-lowering effect of bromocriptine. It is concluded that bromocriptine lowers IOP by stimulation of dopamine-2 receptors.This publication has 8 references indexed in Scilit:
- BROMOCRIPTINE EYEDROPS LOWER INTRAOCULAR PRESSURE WITHOUT AFFECTING PROLACTIN LEVELSThe Lancet, 1984
- BROMOCRIPTINE LOWERS INTRAOCULAR PRESSURE WITHOUT AFFECTING BLOOD PRESSUREThe Lancet, 1983
- MetoclopramideDrugs, 1983
- ALPHA-ADRENOLYTIC PROPERTIES OF BROMOCRIPTINE IN DOGS1982
- A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects.British Journal of Ophthalmology, 1981
- A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugsLife Sciences, 1978
- A NEW TONOMETER SYSTEMOptometry and Vision Science, 1972
- A Simplified Entoptic PupillometerAmerican Journal of Ophthalmology, 1941